SCHEMBL24986908

SCHEMBL24986908

c1ccc(-c2ccc3c(c2)c2ccccc2n3-c2ccc3c(c2)c2ccccc2n3-c2ccc3c4ccccc4n(-c4cccc([Si](c5ccccc5)(c5ccccc5)c5ccccc5)c4)c3c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ATM Q13315 1/20 0.41
TSPO P30536 3/20 0.36
RAC2 P15153 1/20 0.34
RAC3 P60763 1/20 0.34
CDC42 P60953 1/20 0.34
RAC1 P63000 1/20 0.34
HDAC4 P56524 1/20 0.33
PTGER4 P35408 1/20 0.32
EDNRB P24530 1/20 0.32
EDNRA P25101 1/20 0.32
NPY5R Q15761 1/20 0.32
NR3C1 P04150 1/20 0.32
DNM1 Q05193 1/20 0.31
KMT2A Q03164 3/20 0.31
IL1R1 P14778 1/20 0.31
MEN1 O00255 2/20 0.30
GAA P10253 1/20 0.30
RXRA P19793 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24988358 1.00 L3MBTL1 (0.41) L3MBTL1KDM4EATMTSPORAC2
SCHEMBL24987663 1.00 L3MBTL1 (0.41) L3MBTL1KDM4EATMTSPORAC2
SCHEMBL24987888 0.99 L3MBTL1 (0.41) L3MBTL1KDM4EATMTSPORAC2
SCHEMBL24987660 0.98 KDM4E (0.41) L3MBTL1KDM4EATMTSPORAC2
SCHEMBL24988356 0.98 KDM4E (0.41) L3MBTL1KDM4EATMTSPORAC2
SCHEMBL24986906 0.98 KDM4E (0.41) L3MBTL1KDM4EATMTSPORAC2
SCHEMBL24987894 0.96 L3MBTL1 (0.41) L3MBTL1KDM4EATMTSPORAC2
SCHEMBL24089304 0.96 L3MBTL1 (0.41) L3MBTL1KDM4EATMTSPORAC2
SCHEMBL24987905 0.96 L3MBTL1 (0.44) L3MBTL1KDM4EATMTSPORAC2
SCHEMBL24986599 0.96 L3MBTL1 (0.44) L3MBTL1KDM4EATMTSPORAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230019868-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING ORGANIC LIGHT-EMITTING DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230019868-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING ORGANIC LIGHT-EMITTING DEVICE CYP1A1, AOX1, ODC1 L3MBTL1 950/4885KDM4E 3300/4885ATM 3528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.